China National Pharmaceutical Industry Corp

China National Pharmaceutical Industry Corp (CNPIC) is a core industrial subsidiary of Sinopharm, the largest state-owned healthcare group in China. The company is a major player in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Its extensive product portfolio covers critical therapeutic areas such as anti-infectives, cardiovascular medicine, and metabolic disorders. CNPIC operates multiple high-capacity manufacturing bases across China that comply with international GMP standards, supporting both domestic supply and global pharmaceutical trade. As a key component of Sinopharm's industrial arm, the company integrates chemical synthesis expertise with advanced pharmaceutical formulation capabilities.